FDA Inspection
Teva Pharmaceuticals USA, IncTeva Pharmaceuticals USA, Inc – FDA Inspection, Sep 29, 2023
Record Details
This FDA Inspection record concerns Teva Pharmaceuticals USA, Inc, with an inspection on September 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fa424780-712d-4413-b58e-1db04518a9a4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1219319
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- Failure to comply with REMS Implementation System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Pharmaceuticals USA, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | Not classified | New Jersey District Office | |
| December 16, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 2, 2010 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 1, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 14, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceuticals USA, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.